论文部分内容阅读
目的:探讨应用达英35对多囊卵巢综合征(PCOS)患者预处理的临床疗效。方法;将PCOS不孕患者86例随机分为实验组和对照组,实验组48例采用达英35预处理,再用枸橼酸氯米芬促排卵;对照组38例直接用枸橼酸氯米芬促排卵。观察两组患者临床排卵率、妊娠率、流产率及实验组性激素指标的变化。结果:实验组预处理后性激素LH、LH/FSH及T值较处理前差异有统计学意义(P<0.05);两组周期排卵率、妊娠率比较差异有统计学意义(P<0.05),流产率比较差异无统计学意义。结论:采用达英35预处理,可提高PCOS不孕患者的排卵率及妊娠率。
Objective: To investigate the clinical effect of Dayang 35 in pretreatment of patients with polycystic ovary syndrome (PCOS). Methods Eighty-six patients with PCOS infertility were randomly divided into experimental group and control group. 48 cases in experimental group were treated with Da-Ying-35 and ovulation with clomiphene citrate. In the control group, 38 cases were directly treated with citric acid chloride Mi Fen promote ovulation. The clinical ovulation rate, pregnancy rate, abortion rate and changes of sex hormone in experimental group were observed. Results: The LH, LH / FSH and T values of the experimental group after pretreatment were significantly different from those before the treatment (P <0.05). The ovulation rate and pregnancy rate of the two groups were significantly different (P <0.05) Miscarriage rate difference was not statistically significant. Conclusion: Up to 35 pretreatment can increase the ovulation rate and pregnancy rate in patients with PCOS infertility.